Saturday 17 October 2026
Export INFU’s income statement to Excel — free account
InfuSystems Holdings, Inc.
INFU Healthcare Medical Devices
InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024. In the quarter to June 2026, revenue grew 2.59%, EPS grew 33.3%, free cash flow fell 66.5% and total debt fell 22.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
13.33
0.59
−4.24%
Follow INFU
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
28.03 | 84.50 | 267.45 | 0.00 | 243.29 | 21.59 | 121.86 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
8 | 7 | 7 | 5 | 4 | 7 | 7 | 5 | 4 | 4 |
P/S ratio |
1.29 | 1.33 | 1.70 | 1.63 | 3.41 | 3.88 | 2.07 | 1.10 | 0.75 | 0.79 |
Altman Z-Score |
3.74 | 3.25 | 3.36 | 2.54 | 4.74 | 4.78 | 1.82 | 0.76 | 0.51 | 0.98 |
P/FCF ratio |
30.70 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
1.27 | 0.87 | 0.45 | (0.17) | 0.04 | 0.35 | (2.02) | (2.37) | (1.94) | 0.14 |
Beneish M-Score |
(3.30) | (3.24) | (2.72) | (3.21) | (3.14) | (2.42) | (2.94) | (3.58) | (4.51) | (2.92) |
P/Operating CF |
26.00 | 22.66 | 45.99 | 39.34 | 94.17 | 49.61 | 38.77 | 23.16 | 14.78 | 13.28 |
P/B ratio |
3.23 | 3.12 | 4.10 | 3.74 | 7.24 | 9.27 | 7.54 | 3.60 | 1.73 | 1.09 |
Price to Tangible BV |
3.96 | 3.80 | 5.21 | 5.01 | 10.39 | 12.77 | 24.50 | 127.91 | 8.30 | 2.85 |
EV/Sales |
1.41 | 1.51 | 1.93 | 1.94 | 3.73 | 4.18 | 2.52 | 1.54 | 1.10 | 1.23 |
EV/EBITDA |
7.98 | 10.44 | 14.55 | 14.10 | 21.73 | 17.79 | 20.49 | 248.45 | 0.00 | 88.79 |
EV/Operating CF |
8.27 | 9.93 | 21.68 | 12.15 | 20.88 | 20.06 | 14.71 | 9.05 | 10.16 | 10.93 |
EV/FCF |
33.45 | (35.20) | (28.60) | (30.60) | (47.69) | (83.42) | (10.87) | (15.65) | (18.82) | (11.41) |
Quick Ratio |
1.29 | 1.23 | 1.28 | 1.18 | 1.21 | 1.06 | 0.67 | 0.94 | 1.18 | 0.91 |
Current Ratio |
1.80 | 1.82 | 1.95 | 1.71 | 1.71 | 1.29 | 0.88 | 1.19 | 1.42 | 1.26 |
Net Debt/EBITDA |
0.65 | 1.20 | 1.73 | 2.19 | 1.87 | 1.27 | 2.25 | 2.50 | 2.86 | 2.64 |
Debt/Assets |
19.52% | 23.03% | 28.28% | 33.36% | 33.92% | 40.00% | 48.44% | 52.67% | 41.27% | 35.77% |
Debt/Equity |
0.34 | 0.41 | 0.56 | 0.69 | 0.69 | 0.95 | 1.72 | 1.65 | 0.92 | 0.68 |
Asset Turnover |
1.41 | 1.31 | 1.24 | 1.12 | 1.05 | 1.11 | 1.13 | 1.01 | 0.86 | 0.74 |
Operating CF/Net income |
3.68 | 8.72 | 12.87 | 973.17 | 12.90 | 1.17 | 10.19 | (10.40) | (0.37) | (35.63) |
Capex/Depreciation |
(0.40) | (1.05) | (0.53) | (0.85) | (0.90) | (0.87) | (1.59) | (0.44) | 0.07 | (0.46) |
Interest Coverage |
9.18 | 3.88 | 1.88 | 1.18 | 2.05 | 7.03 | 1.85 | 0.29 | (2.86) | 0.72 |
| 11.54% | 4.27% | 1.74% | 0.04% | 3.19% | 54.95% | 6.36% | (4.26%) | (50.73%) | (0.44%) | |
| 6.49% | 2.27% | 0.86% | 0.02% | 1.46% | 19.67% | 1.90% | (1.65%) | (25.07%) | (0.23%) | |
ROIC |
10.10% | 5.33% | 3.15% | 1.28% | 2.17% | 7.89% | 3.79% | 0.52% | (4.26%) | 0.74% |
Return on Tangible Assets |
33.96% | 12.65% | 4.54% | 0.12% | 10.37% | 156.57% | 91.04% | (26.12%) | (303.35%) | (3.51%) |
Average Days of Receivables |
58.28 | 57.26 | 57.54 | 56.02 | 54.92 | 55.17 | 54.43 | 52.15 | 57.95 | 59.96 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
47.67% | 47.09% | 46.92% | 53.59% | 54.42% | 51.27% | 53.45% | 58.32% | 66.37% | 62.08% |
Intangible Assets out of Total Assets |
0.11 | 0.10 | 0.11 | 0.12 | 0.15 | 0.12 | 0.20 | 0.31 | 0.36 | 0.32 |
Share Based Compensation of Revenue |
3.04% | 3.31% | 3.24% | 3.48% | 6.26% | 2.68% | 1.23% | 1.43% | 0.96% | 0.66% |
Graham Net Nets |
(0.04) | (0.08) | (0.09) | (0.15) | (0.08) | (0.07) | (0.22) | (0.35) | (0.38) | (0.45) |
Graham Number |
4.47 | 2.47 | 1.46 | 0.00 | 1.92 | 6.30 | 1.34 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
3.57% | 1.18% | 0.37% | (0.03%) | 0.41% | 4.63% | 0.82% | (1.45%) | (38.97%) | (0.36%) |
Free Cash Flow Yield |
3.26% | (3.21%) | (3.97%) | (3.87%) | (2.29%) | (1.29%) | (11.15%) | (8.94%) | (7.80%) | (13.68%) |
Revenue per Share |
6.94 | 6.34 | 5.98 | 5.32 | 4.99 | 4.84 | 4.11 | 3.13 | 3.13 | 3.12 |
Operating CF per Share |
1.18 | 0.96 | 0.53 | 0.85 | 0.89 | 1.01 | 0.70 | 0.53 | 0.34 | 0.35 |
Capex per Share |
(0.26) | (0.62) | (0.32) | (0.56) | (0.65) | (0.60) | (1.00) | (0.23) | 0.04 | (0.22) |
Free Cash Flow per Share |
0.92 | 0.34 | 0.21 | 0.29 | 0.24 | 0.40 | (0.29) | 0.30 | 0.38 | 0.13 |
Cash per Share |
0.15 | 0.02 | 0.01 | 0.01 | 0.01 | 0.48 | 0.13 | 0.20 | 0.15 | 0.15 |
Shareholders Equity per Share |
2.78 | 2.70 | 2.49 | 2.32 | 2.35 | 2.03 | 1.13 | 0.95 | 1.36 | 2.24 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.78 | 2.70 | 2.49 | 2.32 | 2.35 | 2.03 | 1.13 | 0.95 | 1.36 | 2.24 |
Free Cash Flow |
19.03 | 7.22 | 4.49 | 6.04 | 4.98 | 8.12 | (5.77) | 6.41 | 8.64 | 2.94 |
Working Capital |
16.15 | 14.50 | 14.91 | 10.31 | 9.17 | 6.77 | (2.54) | 2.75 | 5.19 | 4.33 |
Capital Expenditures |
(5.38) | (13.24) | (6.73) | (11.48) | (13.34) | (12.16) | (19.64) | (4.98) | 0.92 | (4.97) |
Net Current Asset Value |
(6.90) | (13.92) | (19.99) | (26.61) | (27.25) | (26.47) | (37.58) | (26.09) | (20.26) | (24.89) |
EV/EBIT |
16.94 | 29.49 | 59.51 | 128.65 | 135.59 | 46.08 | 57.88 | 248.45 | 0.00 | 88.79 |
Capex to Sales |
0.04 | 0.10 | 0.05 | 0.10 | 0.13 | 0.12 | 0.24 | 0.07 | (0.01) | 0.07 |
Price to Operating Income |
15.55 | 26.08 | 52.41 | 108.61 | 123.92 | 42.78 | 47.75 | 177.54 | 0.00 | 56.89 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
3.98 | 3.12 | 2.92 | 3.06 | 3.27 | 3.27 | 3.07 | 7.85 | 7.69 | 5.40 |
Cash ROIC |
23.75% | 8.81% | 5.50% | 7.43% | 6.10% | 9.10% | (9.10%) | 10.95% | 13.74% | 3.31% |
Accounts Receivable Turnover |
6.51 | 6.58 | 6.85 | 6.81 | 6.80 | 7.26 | 7.48 | 6.43 | 6.22 | 5.83 |
Accounts Payable Turnover |
6.11 | 7.22 | 7.67 | 6.09 | 5.99 | 5.24 | 4.55 | 4.37 | 5.12 | 4.33 |
Inventory Turnover |
10.59 | 9.97 | 11.17 | 11.27 | 12.64 | 13.09 | 13.29 | 13.72 | 14.10 | 12.62 |
Average Days of Payables |
62.55 | 55.77 | 46.64 | 61.69 | 65.45 | 64.05 | 84.89 | 93.88 | 72.64 | 75.32 |
Days of Inventory on Hand |
31.16 | 36.97 | 37.28 | 35.65 | 32.79 | 28.36 | 30.91 | 29.84 | 23.23 | 30.69 |
Average Receivables |
22.03 | 20.49 | 18.35 | 16.14 | 15.06 | 13.41 | 10.85 | 10.44 | 11.43 | 12.10 |
Average Payables |
10.33 | 8.93 | 8.18 | 8.10 | 7.32 | 7.37 | 7.53 | 6.30 | 5.42 | 5.95 |
Average Inventory |
5.96 | 6.47 | 5.61 | 4.38 | 3.47 | 2.95 | 2.58 | 2.01 | 1.97 | 2.04 |
Average Assets |
102.09 | 103.26 | 101.15 | 98.49 | 97.29 | 88.11 | 71.65 | 66.48 | 82.61 | 95.85 |
Average Common Equity |
57.43 | 54.92 | 50.15 | 48.14 | 44.51 | 31.54 | 21.39 | 25.70 | 40.82 | 50.50 |
Columns are period end dates